TECHNOLOGY

INNOVATION AT THE INTERSECTION OF PRECISION AND EFFICACY

Microneedle Array Patch (MAP) Technology

Our proprietary MAP platform, the SMArT™ Patch, is designed to deliver vaccines in a revolutionary way. Unlike traditional injection methods, our microneedle patches provide near-painless, precise delivery of vaccines directly to the skin. The unique advantage of our technology is that the precise intended dose is delivered without wastage and without the need for complex applicators.


Landmark's Microneedle SMArT™ Patch

Precision

Exact dosing ensures reliable vaccine delivery.

Patient convenience

Self-administration is possible, reducing the burden on healthcare systems.

Pain-free

No needles, no pain, just highly efficient immunization.

Enhanced stability

Suitable for a wide range of vaccines, including those requiring temperature stability.

THE ADVANTAGES OF MICRONEEDLE TECHNOLOGY

Our microneedle array patch (MAP) platform offers a revolutionary approach to vaccine delivery, combining effectiveness with cost efficiency. This innovative technology provides a range of benefits that make it a game-changer in the healthcare landscape:


Cost-Effectiveness: By eliminating the need for expensive injection equipment and trained healthcare personnel, our MAP platform significantly reduces the overall cost of vaccine administration. This accessibility ensures that vaccines can reach more people, particularly in underserved communities.


Ease of Administration: Designed for simplicity, our microneedle patches can be self-administered, allowing individuals to take control of their vaccinations in a comfortable and familiar setting. This ease of use can lead to higher vaccination rates and improved public health outcomes.


Stability Without Cold Chain: Our technology stabilises vaccines that typically require stringent cold chain conditions, making transportation and storage more manageable. This feature is particularly crucial in remote areas where refrigeration may not be available, ensuring that vaccines remain effective until they reach the patient.


Minimised Discomfort: The ultra-fine microneedles penetrate just the outer layer of the skin, causing minimal discomfort compared to traditional injections. This patient-friendly approach not only alleviates fear associated with needles but also enhances compliance, particularly among populations sensitive to pain.


With these advantages, Landmark Vaccines Limited is committed to transforming vaccine delivery, making it more efficient, accessible, and user-friendly for everyone.

Intellectual Property

Landmark Vaccines Limited is committed to protecting our innovative technologies. We have multiple patents filed and granted, to cover our proprietary microneedle array patch (MAP) delivery system. These patents reflect our leadership in creating next-generation solutions in both vaccine and drug delivery aiming to secure our place as a pioneer in this field.

By protecting our intellectual property, we ensure that Landmark Vaccines can continue to advance its mission while offering cutting-edge solutions to global healthcare challenges.

Get in Touch

Partnership Opportunities:

We are always open to exploring partnerships and collaborations. Contact us to discuss how we can work together.

Media Relations:

For press and media inquiries, please contact our communications team at media@landmarkvaccines.com.

Contact us

Share by: